Ligand validation:7RGA

MTX: METHOTREXATE

MTX is a Ligand Of Interest in 7RGA designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7RGA_MTX_B_301	48%	6%	0.224	0.967	2.63	2.45	9	16	8	0	100%	1
7RGA_MTX_A_301	47%	6%	0.221	0.963	2.17	2.79	7	24	20	0	100%	1
7RGA_MTX_E_301	42%	9%	0.239	0.961	2.01	2.48	8	20	9	0	100%	1
7RGA_MTX_C_301	41%	7%	0.235	0.953	2.31	2.58	8	19	12	0	100%	1
7RGA_MTX_G_301	40%	10%	0.244	0.959	2.05	2.23	4	18	12	0	100%	1
7RGA_MTX_D_301	37%	12%	0.248	0.948	1.97	2.05	8	12	6	0	100%	1
7RGA_MTX_F_301	30%	6%	0.265	0.933	2.31	2.82	8	20	2	0	100%	1
3QXT_MTX_A_2000	92%	9%	0.065	0.954	2.19	2.23	10	18	3	0	100%	1
7RG7_MTX_A_301	88%	15%	0.095	0.969	1.92	1.88	10	14	1	0	100%	1
3QXV_MTX_D_2000	58%	14%	0.139	0.919	1.83	2.01	4	12	4	0	100%	1
9D6X_MTX_D_401	100%	64%	0.041	0.984	0.7	0.67	1	-	2	0	100%	1
1RB3_MTX_B_161	98%	6%	0.049	0.969	2	3.05	11	22	5	0	100%	1
1RA3_MTX_A_161	97%	9%	0.058	0.974	1.61	2.84	8	23	3	0	100%	1
1U72_MTX_A_188	97%	20%	0.065	0.979	1.13	2.23	2	16	4	0	100%	1
1RG7_MTX_A_161	94%	7%	0.071	0.968	1.88	2.93	9	17	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.